Valuation: DIAGNOS Inc.

Market Cap 30.71M 21.65M 18.91M 17.37M 16.2M 2.06B 31.22M 209M 81.04M 1.01B 81.27M 79.51M 3.48B P/E 2025
-6.18x
P/E 2026 -6.51x
Enterprise Value 30.18M 21.28M 18.59M 17.07M 15.92M 2.03B 30.69M 206M 79.66M 993M 79.88M 78.15M 3.42B EV / Sales 2025
293x
EV / Sales 2026 498x
Free-Float
88.96%
Yield 2025 *
-
Yield 2026 -
1 day+2.00%
1 week+13.33%
Current month+2.00%
1 month+13.33%
3 months-7.27%
6 months-29.17%
Current year-32.00%
1 week 0.23
Extreme 0.23
0.26
1 month 0.18
Extreme 0.185
0.26
Current year 0.18
Extreme 0.175
0.38
1 year 0.18
Extreme 0.175
0.42
3 years 0.18
Extreme 0.175
0.59
5 years 0.12
Extreme 0.125
0.6
10 years 0.1
Extreme 0.1
2
Manager TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - 01/05/2008
Chief Operating Officer - 16/01/2024
Director TitleAgeSince
Director/Board Member - 21/09/2000
Director/Board Member 72 28/09/2020
Chairman 69 30/10/2025
Date Insider Type Main position Quantity % Market Cap.
06-11Option

Director

250,000 0.2076%
06-11Option

Director

250,000 0.2076%
06-11Option

Chairman

300,000 0.2491%
Change 5-day change 1-year change 3-year change Capi.($)
+2.00%+13.33%+24.39%-34.62% 21.65M
+1.14%+12.10%+0.65%+116.37% 272B
-0.40%+14.57%+19.70%+47.83% 90.17B
+4.74%+9.16%-54.56%-55.49% 84.05B
+1.49%+0.12%-38.24%-35.81% 78.6B
-0.36%-1.23%-40.15%-10.30% 55.41B
+0.47%+0.90%-35.38%-21.57% 44.25B
-0.54%+3.97%-1.28%+78.19% 36.05B
-0.76%+9.83%+4.20%+194.93% 34.62B
+5.83%+3.47%-33.37%-3.46% 30.64B
Average +1.06%+5.86%-15.40%+27.61% 72.59B
Weighted average by Cap. +0.13%+6.72%-14.26%+50.19%

Financials

2025 2026
Net sales 104K 73.17K 63.94K 58.71K 54.75K 6.97M 106K 707K 274K 3.42M 275K 269K 11.77M 65.48K 46.16K 40.33K 37.04K 34.54K 4.39M 66.58K 446K 173K 2.16M 173K 170K 7.43M
Net income -4.29M -3.02M -2.64M -2.42M -2.26M -288M -4.36M -29.19M -11.31M -141M -11.35M -11.1M -486M -4.56M -3.21M -2.81M -2.58M -2.4M -306M -4.63M -31.02M -12.02M -150M -12.06M -11.8M -517M
Net Debt -164K -115K -101K -92.6K -86.35K -10.99M -166K -1.11M -432K -5.39M -433K -424K -18.57M -525K -370K -323K -297K -277K -35.24M -534K -3.58M -1.39M -17.29M -1.39M -1.36M -59.56M
Logo DIAGNOS Inc.
Diagnos Inc. is a Canadian company, which is engaged in the early detection of critical eye-related health problems using advanced technology based on Artificial Intelligence (AI). It markets Computer Assisted Retinal Analysis (CARA), a software platform which assists health specialists in the detection of certain retinopathy pathologies through the computerized analysis of retina images. CARA is an in-house-hosted Web-based application that integrates fundus cameras with an image processing engine over a secure Internet connection. The CARA suite of applications allows an eye care specialist to more clearly visualize both normal retinal landmarks (optic nerve, vascular system, macula, fovea), and pathological changes (exudates, haemorrhages, micro-aneurisms, neo-vascularization). CARA is indicated for use by healthcare professionals in an adult general population in the context of a general eye-health exam.
Employees
22
Date Price Change Volume
02/07/26 CA$0.2550 +2.00% 102,400
30/06/26 CA$0.2500 +4.17% 132,550
29/06/26 CA$0.2400 +2.13% 171,500
26/06/26 CA$0.2350 +4.44% 150,500
25/06/26 CA$0.2250 -1.10% 140,400

Annual profits - Rate of surprise